Eligo Bioscience Targets Precision Medicine

Eligo Bioscience Targets Precision Medicine

Eligo Bioscience, is a Paris-based next-generation microbiome precision medicine company Eligo Bioscience is pioneering the development of phage-derived DNA delivery vectors for microbial species involved in a number of diseases areas, including infectious diseases, inflammatory diseases and auto-immune diseases. Eligo Bioscience’s EligobioticsTM Plaform EligobioticsTM platform enables the production of DNA delivery vectors derived from phage-like … Read more

Why Biomolecules Are A Key Area Of Synthetic Biology Startup Activity

Why Biomolecules Are A Key Area Of Synthetic Biology Startup Activity

According to McKinsey Global Institute (MGI), several trends in science and technology are powering human understanding of biological processes and enabling us to engineer them for myriad uses. MGI says that innovations cover a wide range of interdisciplinary fields in four key arenas: biomolecules, biosystems, biomachine interfaces, and biocomputing. Major breakthroughs in each are reinforcing … Read more

Sana Biotech Completes Massive Initial Financing Round

Sana Biotech Completes Massive Initial Financing Round

Sana Biotechnology, Inc. (Sana), focused on engineering cells as medicines for patients, announced today the funding of all tranches of its initial financing, raising over $700 million.  Sana’s shareholders include ARCH Venture Partners, Flagship Pioneering, Canada Pension Plan Investment Board, Baillie Gifford, F-Prime Capital, Alaska Permanent Fund, the Public Sector Pension Investment Board, Bezos Expeditions, GV, … Read more